Intrinsiqs

Is Sagimet Biosciences Inc. overvalued?

Sagimet Biosciences Inc. (SGMT) — key valuation metrics and fundamentals.

No verdict
Price
$10.55
Fair value
Current P/E
Normal P/E
Market cap
$343.7M
Dividend yield
0.0%
Return on equity
-32.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares SGMT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.